Home Newsfeeds Maxim Group Downgrades Reed’s to Hold

Maxim Group Downgrades Reed’s to Hold

Maxim Group analyst Anthony Vendetti downgrades Reed's (NASDAQ:REED) from Buy to Hold.

byBenzinga Newsdesk

November 14, 2022

1 minute read

Maxim Group analyst Anthony Vendetti downgrades Reed’s (NASDAQ:REED) from Buy to Hold.

Analyst Ratings

Expert Ratings for Biogen

By Benzinga Insights

November 9, 1:00 PM

Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

BIIB

Bitcoin, Ethereum, Dogecoin Continue To Spike Amid Post-FOMC Cheer: Analyst Says Over $20B Capital Flowing Into BTC, ETH Today

By Mehab Qureshi

December 14, 10:56 PM

The cryptocurrency market witnessed a modest increase on Thursday evening, primarily driven by the Federal Reserve’s (Fed) indication of possible interest rate reductions in the coming year and the positive sentiment surroundin

$DOGE

Data From Incyte’s Povorcitinib Clinical Program To Be Featured At The 8th Annual Symposium On Hidradenitis Suppurativa Advances

By Benzinga Newsdesk

October 13, 8:12 AM

Incyte (NASDAQ:INCY) today announced that multiple abstracts featuring new data from the company's clinical program on povorcitinib, an investigational oral JAK-1 inhibitor, have been accepted for oral presentation at

INCY